| | | Strategies to Drive Clinical Development Success During COVID-19 | | | The COVID-19 pandemic and subsequent social distancing measures around the world have disrupted the clinical trial landscape, bringing an overwhelming degree of stress, anxiety, and uncertainty to ongoing, new, and COVID-19-related clinical development programs. Regulations and guidelines for clinical trial conduct are rapidly evolving and affecting sponsors who are running or planning new clinical studies. We understand that these changes are disrupting your clinical trials. | | | As you consider the impact of COVID-19, there are several key strategies to help you maintain momentum, assess your risks, and minimize the delays for ongoing, new, and COVID-19-related trials. Our agile and scientific-minded experts have compiled a guide of critical strategies for clinical development success during the COVID-19 era, which include: | | | • | | Staying informed of updated, new, and rapidly changing regulations, and working closely with regulatory agencies | | | • | | Implementing operational changes to continue trials in a more virtual ecosystem while still ensuring patient safety | | | • | | Understanding how trial conduct changes will affect your trial’s data integrity |
| | | Read our guide to learn more. | | | |
| |
